News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Evaluating the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in resected NSCLC – IASLC
IASLC/LinkedIn
Nov 18, 2024, 17:34

Evaluating the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in resected NSCLC – IASLC

IASLC posted on X about recent paper by Tae Hee Hong et al., titled “Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC” published on Journal of Thoracic Oncology.

Authors: Tae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, Chris Abbosh, Tiffany Hung, Jörg Bredno, Jill Walker, Xiaojin Shi, Tsveta Milenkova, Leora Horn, Joon Young Choi, Ho Yun Lee, Jong Ho Cho, Yong Soo Choi, Young Mog Shim, Shoujie Chai, Kate Rhodes, Manami Roychowdhury-Saha, Darren Hodgson, Hong Kwan Kim, Myung-Ju Ahn

Evaluating the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in resected NSCLC - IASLC

“This study aimed to evaluate the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in a large cohort of patients with resected NSCLC. Read more about the findings here!”

 

Abhijit Dasgupta cancer Chris Abbosh Darren Hodgson Ho Yun Lee Hong Kwan Kim IASLC Jill Walker Jong Ho Cho Joon Young Choi Jörg Bredno Journal of Thoracic Oncology Kate Rhodes Leora Horn Manami Roychowdhury-Saha Myung-Ju Ahn OncoDaily Oncology Shoujie Chai Soohyun Hwang Tae Hee Hong Tiffany Hung Tsveta Milenkova Xiaojin Shi Yong Soo Choi Young Mog Shim
Special Coverage
Blog
Nov 18, 2024, 17:34
Evaluating the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in resected NSCLC - IASLC
Blog
Nov 18, 2024, 17:31
Audra Moran: Helene Harris Memorial Trust International Forum on Ovarian Cancer
Blog
Nov 18, 2024, 17:22
Estela Rodriguez: Last day of LALCA24 did not disappoint
Blog
Nov 18, 2024, 17:20
Sarah Adomah: What Black women need to support lifestyle changes?
Blog
Nov 18, 2024, 17:16
Wafik S. El-Deiry: Peer-to-peer call challenge delay Folfiri Plus Cetuximab treatment for mCRC
Blog
Nov 18, 2024, 17:13
Vincent Rajkumar: Working on refining response criteria in myeloma
Blog
Nov 18, 2024, 16:59
Refining the First Strike Against EGFR-Mutated Advanced NSCLC - PeerView Institute for Medical Education
Blog
Nov 18, 2024, 16:55
Ruth Fein: Together we can change the conversation around chronic cancers
Blog
Nov 18, 2024, 16:50
Cervical Cancer Elimination Day of Action 2024 - Medicaid Cancer Foundation
Blog
Nov 18, 2024, 16:50
Michael Duruisseaux: Prognostic value of neutrophil to lymphocyte ratio before adjuvant durvalumab in locally advanced NSCLC
Blog
Nov 18, 2024, 16:39
Cristiane Bergerot: Psycology Society suffering in patients with cancer remains a worldwide unmet need
Insight
Nov 18, 2024, 16:36
Very last chance to apply for the CancerX Accelerator Startup